Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

被引:0
|
作者
Yu, MS [1 ]
Ryu, DY [1 ]
Snyderwine, EG [1 ]
机构
[1] NCI, Chem Carcinogenesis Sect, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA
关键词
PhIP; mammary gland; rat;
D O I
10.1002/(SICI)1098-2744(200002)27:2<76::AID-MC3>3.0.CO;2-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhlP), a compound found in cooked meat, is a mammary gland carcinogen in female Sprague-Dawley rats. PhlP-induced rat mammary gland carcinomas were examined for mutations in several genes (exons) known to regulate cell growth and apoptosis, including p53 (4-8), p21(Waf1) (coding region), Apc(14, 15), B-catenin (3), E-cadherin (9,13,15), Bcl-x(coding region), Bar (3), IGFIIR (28), and TGFBIIR (3). DNA from 30 carcinomas was examined by single-strand conformation polymorphism analysis, but no mutations were detected in these genes or gene regions. DNA from carcinomas and matching normal tissue were further screened for allelic imbalance by using a polymerase chain reaction-based approach with primers to known microsatellite regions located throughout the rat genome. Of 53 markers examined, 12 revealed allelic imbalance. Microsatellite instability (MSI) was detected at two markers, one an chromosome 4 and one on chromosome 6. Sixty-five percent and 96% of all carcinomas examined (N=23) showed MSI at these loci on chromosomes 4 and 6, respectively, supporting the notion that MSI plays a role in PhlP-induced mammary carcinogenesis. Loss of heterozygosity (LOH), an indication of a possible tumor suppressor gene, was observed at 10 markers distributed on chromosomes 3, 10, 11, 14, and X. The frequency of LOH at these markers was 75-94%, supporting that the regions of allelic imbalance were largely similar for the PhlP-induced carcinomas examined in this study. When PhlP-induced carcinomas from rats placed on high-fat and low-fat diet were compared, no unique regions of allelic imbalance or statistical differences in the frequency of allelic imbalance were observed. Therefore, the high-fat diet, known to be a promoter of PhlP-induced rat mammary carcinogenesis, did not appear to influence allelic imbalance in the carcinomas. Interestingly, 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas did not show allelic imbalance at 11 of the 12 loci that showed allelic imbalance in PhlP-induced carcinomas. These findings suggest that distinct chemical carcinogens induce different patterns of allelic imbalance during rat mammary carcinogenesis. Since several of the known genes involved in carcinogenesis did not harbor mutations in PhlP-induced carcinomas, further studies are needed to clarify the critical genes involved in PhlP-induced mammary carcinogenesis and to determine whether regions of LOH harbor potentially novel tumor suppressor genes involved in this disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [21] Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Toyota, M
    Ushijima, T
    Weisburger, JH
    Hosoya, Y
    Canzian, F
    Rivenson, A
    Imai, K
    Sugimura, T
    Nagao, M
    MOLECULAR CARCINOGENESIS, 1996, 15 (03) : 176 - 182
  • [22] Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats
    Nagao, M
    Ushijima, T
    Watanabe, N
    Okochi, E
    Ochiai, M
    Nakagama, H
    Sugimura, T
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) : 158 - 164
  • [23] H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer
    Yu, MS
    Snyderwine, EG
    CARCINOGENESIS, 2002, 23 (12) : 2123 - 2128
  • [24] FRIEDLANDER SYNTHESIS OF THE FOOD CARCINOGEN 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE
    LINDSTROM, S
    ACTA CHEMICA SCANDINAVICA, 1995, 49 (05): : 361 - 363
  • [25] DNA-BINDING AND DISPOSITION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) IN THE RAT
    DRAGSTED, LO
    FRANDSEN, H
    REISTAD, R
    ALEXANDER, J
    LARSEN, JC
    CARCINOGENESIS, 1995, 16 (11) : 2785 - 2793
  • [26] Active secretion of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) in the colon
    von Keutz, A.
    Schroeder, B.
    Breves, G.
    Steinberg, P.
    Nicken, P.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 63 - 63
  • [27] Comparison of crystal structure and theory for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Parkin, S
    Marsch, GA
    Hope, H
    Whitney, E
    Winter, NW
    Colvin, ME
    Felton, JS
    Turteltaub, KW
    CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (03) : 574 - 579
  • [28] Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
    Gooderham, NJ
    Zhu, H
    Lauber, S
    Boyce, A
    Creton, S
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 506 : 91 - 99
  • [29] A NEW COLON AND MAMMARY CARCINOGEN IN COOKED FOOD, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP)
    ITO, N
    HASEGAWA, R
    SANO, M
    TAMANO, S
    ESUMI, H
    TAKAYAMA, S
    SUGIMURA, T
    CARCINOGENESIS, 1991, 12 (08) : 1503 - 1506
  • [30] Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Ochiai, M
    Ushigome, M
    Fujiwara, K
    Ubagai, T
    Kawamori, T
    Sugimura, T
    Nagao, M
    Nakagama, H
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04): : 1607 - 1614